15
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Relapse of Chronic Myelogenous Leukemia 12 Years After Allogeneic Marrow Transplantation: Successful Second Transplantation with Allogeneic Peripheral Blood Progenitor Cells

, , , , , , , & show all
Pages 215-218 | Received 17 Mar 2000, Published online: 01 Jul 2009

References

  • Gratwohl A, Hermans J, Niederwieser D. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Bone Marrow Transplant 1993; 12: 509–516
  • Goldman JM, Szydlo R, Horowitz MM. Choice of pre-transplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 1993; 7: 2235–2238
  • Van Rhee F, Szydlo RM, Hermans J. Long term results after allogeneic bone marrow transplantation for chronic myeloid leukemia in chronic phase: a report from the CLWP of the EBMT. Bone Marrow Transplant 1997; 20: 553–560
  • Van Rhee F, Lin F, Cross NC. Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia. Bone Marrow Transplant 1994; 14: 609–612
  • Guimaraes A, Machado A, Carvalho S. Relapsed chronic myeloid leukemia in accelerated phase 10 years after allogeneic bone marrow transplantation: full chimera reconversion with donor peripheral blood stem cells infusion. Bone Marrow Transplant 1998; 22: 595–597
  • Kolb HJ, Mittermiiller J, Clemm C. Donor leukocyte transfusion for treatment of recurrent chronic myeloid leukemia in marrow transplantation patients. Blood 1990; 76: 2462–2465
  • Cullis JO, Marks DI, Schwarer AP. Relapse into blast crisis following bone bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five cases. British J Haematol 1992; 81: 378–382
  • Barrett AJ, Locatelli F, Treleaven JG. Second transplants for leukemic relapse after bone marrow transplantation: High early mortality but favourable effect of chronic GVHD on continued remission. Br J Haematol 1991; 79: 567–574
  • Mrsic M, Horowitz MM, Atkinson K. Second HLA-identical sibling transplants for leukemic recurrence. Bone Marrow Transplant 1992; 9: 269–275
  • Harnden DG, Klinger HP. An international system for human cytogenetic nomenclature. Karger, BaselSwitzerland 1985
  • Bentz M, Cabot G, Moos M. Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 1994; 83: 1922–1928
  • Mitterbauer G, Fodinger M, Scherrer R. PCR-monitoring of minimal residual leukemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL positive acute lymphoblastic leukemia. Br J Haematol 1995; 89: 937–941
  • Gaiger A, Mannhalter C, Hinterberger W. Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene. Ann Hematol 1991; 63: 227–228
  • Storb R, Deeg HJ, Whitehead J. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729–735
  • Rowlings PA, Przepiorka D, Klein JP. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997; 97: 855–864
  • Schmitz N, Bacigalupo A, Hasenclever D. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 995–1003
  • Radich JP, Gehly G, Gooley T. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia; results and implications in 346 patients. Blood 1995; 85: 2632–2638

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.